Patents Assigned to Schering-Plough Animal Health Corp.
  • Recombinant infectious laryngotracheitis virus and uses thereof
    Patent number: 7892564
    Abstract: The present invention provides a recombinant, attenuated infectious laryngotracheitis virus comprising the infectious laryngotracheitis viral genome which contains a deletion in the glycoprotein gG gene. This attenuated virus is useful as a vaccine against infectious laryngotracheitis virus. The present invention also provides a recombinant, attenuated infectious laryngotracheitis virus comprising the infectious laryngotracheitis viral genome which contains a deletion in the US2 gene, UL47-like gene, ORF4 gene or glycoprotein g60 gene. The present invention also provides a method for distinguishing chickens or other poultry vaccinated with a recombinant infectious laryngotracheitis virus which produces no glycoprotein gG from those infected with a naturally-occurring infectious laryngotracheitis virus.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: February 22, 2011
    Assignee: Schering-Plough Animal Health Corp.
    Inventors: Martha A. Wild, Mark D. Cochran
  • Eta-1 gene and methods for use
    Patent number: 7780965
    Abstract: The present application relates to osteopontin (Eta-1) polypeptides, nucleic acids that encode Eta-1, antibodies that specifically bind to Eta-1, and methods for enhancing an immune response in an animal.
    Type: Grant
    Filed: November 21, 2006
    Date of Patent: August 24, 2010
    Assignee: Schering-Plough Animal Health Corp.
    Inventors: Barbara J. Winslow, Dalia Kalabat
  • Growth stimulant compositions
    Patent number: 7767708
    Abstract: An improved weight and growth stimulant for domesticated animals such as cattle, pigs and sheep is comprised of an anabolic agent that is subcutaneously administered in the form of a dual release implant formulation. Increased gains are particularly improved when zeranol is administered in an immediate-release and controlled-release formulation which allows for a one-time dosage injection.
    Type: Grant
    Filed: November 1, 1999
    Date of Patent: August 3, 2010
    Assignee: Schering-Plough Animal Health Corp.
    Inventors: Shih Chung, Thomas J. Kennedy, Peter James Knight, Daniel S. Robins, Zezhi Jesse Shao
  • Florfenicol prodrug having improved water solubility
    Patent number: 7572777
    Abstract: The present invention discloses methods of using phosphate esters of florfenicol (prodrugs) and florfenicol analogs having superior water solubility that are hydrolyzed to florfenicol or the respective florfenicol analog in vivo, upon administration to an animal.
    Type: Grant
    Filed: August 29, 2006
    Date of Patent: August 11, 2009
    Assignee: Schering-Plough Animal Health Corp.
    Inventors: Scott J. Hecker, Sunil V. Pansare, Tomasz W. Glinka
  • Recombinant infectious laryngotracheitis virus and uses thereof
    Patent number: 7501491
    Abstract: The present invention provides a recombinant, attenuated infectious laryngotracheitis virus comprising the infectious laryngotracheitis viral genome which contains a deletion in the glycoprotein gG gene. This attenuated virus is useful as a vaccine against infectious laryngotracheitis virus. The present invention also provides a recombinant, attenuated infectious laryngotracheitis virus comprising the infectious laryngotracheitis viral genome which contains a deletion in the US2 gene, UL47-like gene, ORF4 gene or glycoprotein g60 gene. The present invention also provides a method for distinguishing chickens or other poultry vaccinated with a recombinant infectious laryngotracheitis virus which produces no glycoprotein gG from those infected with a naturally-occurring infectious laryngotracheitis virus.
    Type: Grant
    Filed: March 13, 2008
    Date of Patent: March 10, 2009
    Assignee: Schering-Plough Animal Health Corp.
    Inventors: Martha A. Wild, Mark D. Cochran
  • Recombinant infectious laryngotracheitis virus and uses thereof
    Patent number: 7364893
    Abstract: The present invention provides recombinant and/or isolated infectious laryngotracheitis virus glycoproteins, including gD, gI, gG and gE.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: April 29, 2008
    Assignee: Schering-Plough Animal Health Corp.
    Inventors: Martha A. Wild, Mark D. Cochran
  • Aqueous insecticidal pour-on formulation
    Patent number: 6492419
    Abstract: A topically acceptable aqueous pour-on formulation adapted for localized external application to an animal, which format includes an effective amount of a water insoluble insect growth regulator (IGR), a suspending agent, a surfactant or mixture of surfactants, and an aqueous carrier.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: December 10, 2002
    Assignee: Schering-Plough Animal Health Corp.
    Inventor: Stanley Shepherd